Chlorambucil
Chlorambucil (Leukeran) is a chemotherapy medicine used in chronic lymphocytic leukaemia and Hodgkin’s lymphoma. This page presents the one listed formulation, covering both conditions the medicine treats.
Key points
- Chlorambucil is an alkylating agent, a type of chemotherapy medicine that works by stopping cancer cells from growing and multiplying.
- The listed formulation is a 2 mg tablet, the sole product in this catalogue, originating from the brand Leukeran, first developed by GlaxoSmithKline.
What Chlorambucil is used for
Chlorambucil is an alkylating agent used in chronic lymphocytic leukaemia and Hodgkin’s lymphoma. The single listed product is Leukeran, a 2 mg tablet of chlorambucil from the originator brand by GlaxoSmithKline. It falls under Oncology Support, covering medicines used in cancer care.
